Durkin Bryan T's Form 4 filing
CME Group Inc. (CME) · filed Nov 8, 2021
- Accession no.
- 0001156375-21-000173
- Filed
- Nov 8, 2021
- Trade date
- Nov 5, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $2.22M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Durkin Bryan TCIK 0001341363 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock Class A | SSaleDisposed | −6,583 | $222.40 | −$1,464,059.2 | 71,704 | Direct | |
| Nov 5, 2021 | Common Stock Class A | SSaleDisposed | −3,238 | $221.46 | −$717,087.48 | 68,466 | Direct | |
| Nov 5, 2021 | Common Stock Class A | SSaleDisposed | −179 | $220.76 | −$39,516.04 | 68,287 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.